| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 3,000 | ₹0.85 -22.72% | 2,250-10% |
| - | - | 3,100 | ₹1.2 20% | 9,000414.28% |
| 2500% | ₹470 0% | 3,200 | ₹2.1 -14.28% | 11,250125% |
| - | - | 3,250 | ₹2.6 1.96% | 6,500-42.22% |
| 75050% | ₹245.85 -15.8% | 3,300 | ₹3.75 15.38% | 21,00020% |
| 1,0000% | ₹253 0% | 3,350 | ₹6.15 32.25% | 12,750218.75% |
| 1,50050% | ₹153.6 -18.01% | 3,400 | ₹10.4 31.64% | 62,50017.37% |
| 1,000-20% | ₹112.3 -30.24% | 3,450 | ₹19.45 33.67% | 9,50015.15% |
| 12,75037.83% | ₹77.95 -24.35% | 3,500 | ₹31.95 32.57% | 61,25016.66% |
| 25,750415% | ₹49.95 -41.23% | 3,550 | ₹52.95 26.82% | 29,0002.65% |
| 1,16,00019.58% | ₹30.4 -35.25% | 3,600 | ₹85.1 28.64% | 43,000-3.37% |
| 1,23,7502.69% | ₹17.05 -41.6% | 3,650 | ₹131.35 36.04% | 12,250-3.92% |
| 1,25,5006.80% | ₹11 -39.39% | 3,700 | ₹161.1 14.58% | 3,5007.69% |
| 29,5004.42% | ₹7.25 -33.17% | 3,750 | ₹173.7 0% | 1,0000% |
| 74,25013.35% | ₹4.9 -33.78% | 3,800 | ₹252 10.62% | 1,00033.33% |
| 28,2509.70% | ₹3.35 -33% | 3,850 | ₹300 8.26% | 5000% |
| 38,500-13.48% | ₹2.3 -36.98% | 3,900 | - | - |
| 49,000-14.41% | ₹1.5 -36.17% | 4,000 | ₹345 0% | 2500% |
| 2500% | ₹18 0% | 4,100 | - | - |
| 1,2500% | ₹6 0% | 4,200 | - | - |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
